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Natural killer (NK) cell cytotoxicity toward target
cells depends on synergistic coactivation by NK cell
receptors such as NKG2D and 2B4. How synergy
occurs is not known. Synergistic phosphorylation
of phospholipase PLC-g2, Ca2+ mobilization, and
degranulation triggered by NKG2D and 2B4 coen-
gagement were blocked by Vav1 siRNA knockdown,
but enhancedby knockdownof c-Cbl. c-Cbl inhibited
Vav1-dependent signals, given that c-Cbl knockdown
did not rescue the Vav1 defect. Moreover, c-Cbl
knockdown and Vav1 overexpression each circum-
vented the necessity for synergy because NKG2D
or 2B4 alone became sufficient for activation. Thus,
synergy requires not strict complementation but,
rather, strong Vav1 signals to overcome inhibition
by c-Cbl. Inhibition of NK cell cytotoxicity by CD94-
NKG2A binding to HLA-E on target cells was domi-
nant over synergistic activation, even after c-Cbl
knockdown. Therefore, NK cell activation by syner-
gizing receptors is regulated at the level of Vav1 by
a hierarchy of inhibitory mechanisms.
INTRODUCTION
Activation of natural killer (NK) cells relies on the integration of
signals from ‘‘coactivation’’ receptors, which bind endogenous
‘‘self’’ ligands on target cells (Bryceson et al., 2006a; Lanier,
2005), in contrast to the activation of T and B cells, which is domi-
nated by antigen-specific receptors selected to not react with
‘‘self.’’ Thus, NK cell cytotoxicity toward target cells is tempered
by a requirement for combined signals from multiple activating
receptors (Bryceson et al., 2006a; Lanier et al., 1997; Pende
et al., 2001). In addition, inhibitory receptors, including receptors
specific for MHC class I and receptors that bind non-MHC mole-
cules on target cells, antagonize signals from activating recep-
tors, thereby also providing protection of healthy cells from lysis
by NK cells (Long, 2008).
Signaling pathways triggered by individual NK cell receptors
have been characterized to some extent (Bryceson et al.,2006a; Vivier et al., 2004), but one of the key unresolved ques-
tions is how signals delivered by several different receptors on
NK cells are integrated in order to result in appropriate functional
responses (Di Santo, 2008). A difficulty in the study of NK cell
responses is the multiplicity of receptor-ligand interactions
between NK cells and target cells, including ligands, and per-
haps receptor-ligand pairs, that have not been identified yet
(Bryceson and Long, 2008; Tassi et al., 2006). Primary, resting
NK cells isolated from human blood do not respond to single
activating receptors but require coengagement of specific pairs
of activating receptors (Bryceson et al., 2009; Bryceson et al.,
2006b). Understanding the basis for such synergy should
provide insight into the regulation of NK cell cytotoxicity and
cytokine production.
Among the pairwise combinations of receptors that synergize
to activate resting NK cells are NKG2D (CD314) and 2B4
(CD244), and 2B4 and DNAM-1 (CD226). The combination of
NKG2D and DNAM-1 does not synergize. This kind of informa-
tion has been useful in determining the sensitivity of primary
tumor cells to lysis by primary NK cells (Carlsten et al., 2007).
The natural ligands of NKG2D are stress-inducible MICA,
MICB, and the small family of ULBP molecules (Bauer et al.,
1999; Cosman et al., 2001). NKG2D associates with DAP10, a
small signaling subunit that recruits either phosphatidylinositol-
3-kinase (PI3K) or Grb2-Vav1 through its phosphorylated tyro-
sine (Graham et al., 2006; Upshaw et al., 2006). The ligand of
2B4, CD48, is broadly expressed on hematopoietic cells. 2B4
carries several tyrosines in its cytoplasmic tail, which recruit
the small adaptor SAP bound to the tyrosine kinase Fyn
(Bloch-Queyrat et al., 2005).
Synergistic NK cell activation by two co-activation receptors
could be due to a strict complementation, whereby enhanced
signaling by either one of the receptors would not overcome
the lack of signals from the other. Alternatively, synergistic sig-
nals may be required to overcome a high threshold for activation.
In the latter hypothesis, enhanced signaling by each receptor
may suffice to activate NK cell responses. In this study, we
sought to test these hypotheses and to identify signaling mole-
cules required for NKG2D and 2B4 synergy. Signaling during
synergistic activation was studied not only by receptor ligation
with antibodies (Abs), but also in the context of defined and
physiological receptor-ligand interactions, which was achieved
by using Drosophila S2 cells as target cells. Primary, resting
NK cells, or the cell line NKL after a period of rest, were usedImmunity 32, 175–186, February 26, 2010 ª2010 Elsevier Inc. 175
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activation in the absence of exogenous cytokines. The results
revealed that the guanine exchange factor Vav1 and the E3
ubiquitin ligase c-Cbl act coordinately to control NKG2D and
2B4 synergy, and uncovered a previously unappreciated role
of c-Cbl as a gatekeeper for NK cell activation.
RESULTS
NKG2D and 2B4 Synergy Induces Degranulation
but Not Polarization
Drosophila Schneider line 2 (S2) cells with stable expression
of either ULBP1, CD48, or both were generated (Figure S1A
available online) in order to trigger NKG2D and 2B4 synergy in
the context of natural ligands at the surface of a cell. Primary,
resting NK cells were incubated with S2 cells for 2 hr, and
degranulation was measured by the cell-surface appearance of
CD107a (LAMP-1). As shown with S2 cells with inducible expres-
sion of ULBP1 and CD48 (Bryceson et al., 2009), each ligand
alone induced little degranulation, whereas ULBP1 and CD48
coexpression resulted in degranulation by 13% of NK cells
(Figure S1B), which was comparable to the degranulation trig-
gered by antibody-dependent cellular cytotoxicity (ADCC)
(Figure S1B). To test whether synergy between NKG2D and
2B4 induced polarization of cytolytic granules, as well as degran-
ulation, we examined polarization of perforin-containing gran-
ules. NK-target cell conjugates were scored for polarization by
confocal microscopy, with reconstructed 3D images. ICAM-1
expression on S2 cells induced granule polarization in 70%
of NK cells (Figure S1C), as reported (Bryceson et al., 2005). In
contrast, expression of ULBP1, CD48, or ULBP1 and CD48 on
S2 cells triggered little or no granule polarization beyond the
background from the random polarization observed with un-
transfected S2 cells (Figure S1C). Therefore, signals from
NKG2D, 2B4, and the combination of NKG2D and 2B4 did not
induce granule polarization. Granules ‘‘predocked’’ at the
plasma membrane in resting NK cells provide a source of cyto-
lytic granules ready to fuse for degranulation in the absence of
polarization of the bulk of cytolytic granules (Liu et al., 2009).
The uncoupling of signals for polarization and for degranulation
provided us with a unique tool to study the signaling pathways
underlying synergistic activation of degranulation.
Synergistic Activation of PLC-g2 by NKG2D
and 2B4 Coengagement
Signaling molecules reportedly associated with degranulation in
NK cells include PLC-g, PI3K, and the mitogen-associated
protein kinase (MAPK) Erk (Bryceson et al., 2006a; Caraux
et al., 2006; Chen et al., 2006; Jiang et al., 2000; Tassi et al.,
2007). Their role in the synergy required to induce degranulation
was therefore investigated. NKG2D and 2B4 on resting NK cells
were stimulated, either individually or together, by preincubation
with specific mAbs followed by crosslinking with goat F(ab0)2
anti-mouse IgG. Whereas stimulation of either NKG2D or 2B4
alone induced little phosphorylation of PLC-g2 and Erk, coen-
gagement of NKG2D and 2B4 led to a synergistic increase in
their phosphorylation; such an increase was evident after 2 min
and decreased thereafter (Figure 1A). In contrast, phosphoryla-
tion of Akt, which is downstream of PI3K activation, was de-176 Immunity 32, 175–186, February 26, 2010 ª2010 Elsevier Inc.tected by crosslinking NKG2D, as expected (Sutherland et al.,
2002), but not 2B4, and was not increased by coengagement
of NKG2D and 2B4 (Figure 1A). Therefore, synergy is not simply
due to enhanced signaling by NKG2D. The weak phosphoryla-
tion of PLC-g2 and of Erk and the lack of Akt phosphorylation
after 2B4 crosslinking could be due to a failure of 2B4 to signal
under our conditions. However, phosphorylation of 2B4 and
recruitment of the adaptor SAP were clearly observed after
2B4 crosslinking and were not enhanced by co-crosslinking
NKG2D with 2B4 (Figure S1D). This result implies that synergy
between NKG2D and 2B4 is not at the level of 2B4 phosphoryla-
tion. Although phosphorylation of PLC-g2, Akt, and Erk upon
stimulation with NKG2D and 2B4 varied somewhat among
resting NK cells from different donors, reproducible and consis-
tent results were obtained for the synergistic phosphorylation of
PLC-g2 and Erk and for NKG2D-mediated phosphorylation of
Akt. Thus, coengagement of NKG2D and 2B4 induces signals
for synergistic activation of PLC-g2 and Erk.
Although synergistic degranulation induced by S2 cells ex-
pressing ULBP1 and CD48 was blocked by inhibition of both
PLC-g (U73122) and PI3K (LY294002 and wortmannin) (data
not shown), PI3K was dispensable for transmission of synergistic
signals, given that it was not required for the phosphorylation of
PLC-g2, and only partially for Erk activation (Figure 1B). Further,
synergistic increase in Ca2+ mobilization, which is required for
degranulation and typically depends on PLC-g activation, was
insensitive to PI3K inhibitors (data not shown). Moreover, the
PLC-g inhibitor U73122, but not its inactive analog U73343,
completely abrogated synergistic Erk phosphorylation (Fig-
ure 1C). These data suggest that PLC-g, rather than PI3K, is a
critical upstream regulator of Erk activation. Taken together,
our results suggest an important role of PLC-g but not PI3K in
synergistic signaling by NKG2D and 2B4.
Because the supply of freshly isolated NK cells is limited, and
because in vitro expansion of NK cells in the presence of cyto-
kines changes their signaling properties, we screened human
NK cell lines for a suitable surrogate of resting NK cells that could
be used to study molecular signals underlying synergy. Among
the cell lines NK92, NKL, NK3.3, and YTS, only NKL cells repro-
duced the synergistic increase in phosphorylation of PLC-g2 and
Erk, Ca2+ mobilization, and cytotoxic activity when stimulated by
NKG2D and 2B4 coengagement (Figures S1E–S1H). NKL cells
acquired these properties after 24 hr of IL-2 deprivation in a
low serum concentration. Therefore, NKL cells were chosen for
studying NKG2D and 2B4 synergy.
Vav1 Is Required for NKG2D and 2B4 Synergy
NKG2D signals through either PI3K or Grb2-Vav1 (Graham et al.,
2006; Upshaw et al., 2006). The PI3K-independent signaling by
NKG2D during synergy suggested that NKG2D may signal
through recruitment of Vav1 bound to the adaptor Grb2. Vav
proteins, which include Vav1, Vav2, and Vav3, have a central
role in the regulation of actin cytoskeleton dynamics and
lymphocyte-receptor signaling (Tybulewicz, 2005). Furthermore,
Vav1 is a preferred substrate of the tyrosine phosphatase SHP-1
during inhibition of NK cell cytotoxicity by MHC class I-specific
inhibitory receptors, suggesting that Vav1 may be a central regu-
lator of NK cell cytotoxicity (Peterson and Long, 2008; Stebbins
et al., 2003). We therefore tested whether Vav proteins were
Figure 1. Synergistic Phosphorylation of PLC-g2 by NKG2D and 2B4
Coengagement
(A) Freshly isolated, resting NK cells were preincubated with mAbs specific for
NKG2D and/or 2B4 on ice for 30 min and stimulated by crosslinking with
secondary goat F(ab0)2 anti-mouse IgG at 37C for the indicated time. Lysates
were resolved on a 4% to 12% SDS-PAGE, transferred to a polyvinylidene di-
fluoride (PVDF) membrane, and immunoblotted with Abs to phospho-PLC-g2
at tyrosine 759 (pY759) or at tyrosine 1217 (pY1217), phospho-Akt at serine
473 (pS473), or phospho-Erk1 and 2. After stripping, the blots were reprobed
with Abs to PLC-g2, Akt and to Erk1 and Erk2. The normalized intensities of the
phosphorylated PLC-g2, Akt, and Erk1 and 2 relative to their total forms were
quantified with ImageJ software and are presented for each condition.
(B) Resting NK cells were preincubated with isotype control mAb or mAbs
specific for NKG2D and/or 2B4 in the absence or presence of the PI3K inhibitor
LY294002 at 20 mM for 30 min. After receptor crosslinking for 2 min in the pres-
ence of the inhibitor, cells were lysed and the lysates were immunoblotted with
Abs to phospho-PLC-g2 at tyrosine 759 (pY759) or at tyrosine 1217 (pY1217),
phospho-Akt at serine 473 (pS473), or phospho-Erk1 and 2. The blot was strip-
ped and reprobed for actin for monitoring sample loading.
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and 2B4 synergy. The synergistic increase in Ca2+ mobilization
and cytotoxicity were markedly diminished by knockdown
(Figure S2A) of Vav1, but not Vav2 or Vav3 (Figures 2A and
2B), by small interfering RNA (siRNA) in rested NKL cells. Syner-
gistic signals for IFN-g and MIP-1a release by NKL cells stimu-
lated with beads coated with mAbs to NKG2D and 2B4 were
also abrogated by Vav1 knockdown (Figure 2C). The complete
dependence on Vav1 was more striking than the phenotype of
Vav1/ mouse NK cells, which retained partial cytotoxic activity
toward sensitive target cells (Chan et al., 2001; Colucci et al.,
2001) and is also consistent with the selective use of Vav1, but
not Vav2 or Vav3, by the NKG2D-DAP10 signaling pathway in
NK cells (Cella et al., 2004).
Activation of the guanine exchange factor (GEF) activity of Vav1
is accompanied by Vav1 tyrosine phosphorylation. This phos-
phorylation includes tyrosine 160, which is one of three regulatory
tyrosines (Bustelo, 2001). NKG2D and 2B4 each induced Vav1
phosphorylation independently in rested NKL cells (Figure 2D).
Similar results of Vav1 phosphorylation were obtained with
primary resting NK cells (Figure S2B). Vav1 phosphorylation
induced by NKG2D and 2B4 synergy was equivalent to the sum
of the phosphorylation induced by each receptor. Therefore,
synergistic activation of NK cells is not due to a complementarity
of NKG2D and 2B4 signals for Vav1 phosphorylation.
The role of Vav1 on downstream signaling, such as phosphor-
ylation of PLC-g2 and Erk, during NKG2D and 2B4 synergy was
tested by Vav1 knockdown in NKL cells. Phosphorylation of
PLC-g2 and of Erk was almost eliminated (Figure 2E), in agree-
ment with the control of PLC-g and Erk activation by Vav1 in
T cells (Reynolds et al., 2004; Reynolds et al., 2002).
To test whether Vav1 was required for synergistic activation of
NK cells by a different combination of coactivation receptors,
resting NK cells and NKL cells were examined after coengage-
ment of receptor DNAM-1 with 2B4 and with NKG2D. DNAM-1
synergizes with 2B4 but not with NKG2D for Ca2+ mobilization
and cytotoxicity (Bryceson et al., 2006b). Crosslinking DNAM-1
alone induced phosphorylation of Vav1 at tyrosine 160, but little
or no phosphorylation of PLC-g2 and of Erk (Figures S2C and
S2D). However, DNAM-1 synergy with 2B4 for Ca2+ mobilization
and cytotoxicity was almost equivalent to that of NKG2D and
2B4 and was markedly impaired by Vav1 knockdown (Figures
S2E and S2F), underscoring the pivotal role of Vav1 in synergistic
activation through different combinations of receptors.Synergistic Activation Is Susceptible to Inhibition
by CD94-NKG2A
To test synergistic activation in the context of receptor-ligand
interactions, we mixed NKL cells with S2 cells expressing
ULBP1 and CD48, either alone or in combination. Tyrosine phos-
phorylation of Vav1, including that of tyrosine 160, was induced(C) Resting NK cells were preincubated with isotype control mAb or mAbs
specific for NKG2D and/or 2B4 in the presence of a PLC-g inhibitor
(U73122; 5 mM) or its inactive analog (U73343; 5 mM) for 30 min. After receptor
crosslinking for 2 min in the presence of inhibitors, cells were lysed and the
lysates were immunoblotted with Abs to phospho-Erk1 and 2. The blot was
stripped and reprobed for actin. Data are representative of at least four inde-
pendent experiments.
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Figure 2. Vav1 Is Required for NKG2D and
2B4 Synergy
(A) NKL cells were transfected with 300 pmoles of
control siRNA or siRNA specific for Vav1, Vav2, or
Vav3. After 24 hr, the cells were rested in 5% FBS-
containing medium in the absence of IL-2 for
another 24 hr, loaded with Fluo-4 at 30C for
30 min, resuspended in HBSS containing 1%
FBS, and preincubated with mAbs for NKG2D
and 2B4. Cells were prewarmed at 37C and
analyzed by flow cytometry. After 30 s, goat
F(ab0)2 anti-mouse IgG was added to crosslink
the receptors. Changes in fluorescence are shown
as a function of time.
(B) Redirected lysis of P815 cells by rested NKL
cells transfected with the indicated siRNAs at the
indicated effector to target cell ratios (E:T). Cyto-
toxicity against P815 cells preincubated with
mAbs specific for NKG2D and 2B4 was deter-
mined after 2 hr with the Europium assay. Error
bars represent the SD.
(C) Cytokine release assays with rested NKL cells
after transfection with control siRNA or Vav1-
specific siRNA and stimulation with beads coated
with isotype control mAb (cIgG1) or mAbs specific
for NKG2D and/or 2B4. After incubation for 16 hr,
IFN-g and MIP-1a in the supernatants were
measured by ELISA. Values represent mean ± SD.
(D) Rested NKL cells were treated as in Figure 1A
to stimulate NKG2D and/or 2B4 at 37C for the
indicated time. Lysates were immunoprecipitated
with Ab to Vav1, immunoblotted with anti-p-Tyr
mAb or anti-pY160-Vav1 Ab, and reprobed for
Vav1. The normalized intensities of the phosphor-
ylated Vav1 at tyrosines or at tyrosine 160 relative
to total Vav1 are presented.
(E) Rested NKL cells that were mock-transfected
or transfected with control siRNA or Vav1-specific
siRNA were stimulated with isotype control mAb (cIgG1) or mAbs specific for NKG2D and 2B4. After receptor crosslinking for 2 min, lysates were immunoblotted
for pY1217-PLC-g2, p-Erk1 and 2, or Vav1. After stripping, the blots were reprobed for actin. Data are representative of at least four independent experiments.
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seen after crosslinking receptors with Abs (Figure 2), mixing
with S2 cells expressing both ligands (S2-ULBP1 + CD48) re-
sulted in greater phosphorylation of Vav1, corresponding to the
sum of the phosphorylation induced by single receptor engage-
ment (Figure 3A). In contrast, Granzyme B release depended on
the synergistic combination of ligands for both NKG2D and 2B4,
and was greatly reduced after Vav1 knockdown (Figure 3B).
These results, obtained in the context of receptors interacting
with their physiological ligands, confirm that Vav1 is essential
for activation of NK cell effector function through NKG2D and
2B4 synergy.
Given that Vav1 is a primary target for dephosphorylation
during inhibition through MHC class I-specific inhibitory recep-
tors (Peterson and Long, 2008; Stebbins et al., 2003), one would
expect Vav1-dependent synergistic signaling by NKG2D and
2B4 to be susceptible to inhibition. Indeed, degranulation by
resting NK cells induced by the ligands ULBP1 and CD48 was in-
hibited by coexpression of HLA-E (Bryceson et al., 2009). To test
the effect of inhibition on Vav1 phosphorylation, we incubated
NKL cells, which express the inhibitory receptor CD94-NKG2A,
with transfected S2 cells expressing ULBP1, CD48, and HLA-E
(Figure S3). Coexpression of peptide-loaded HLA-E inhibited178 Immunity 32, 175–186, February 26, 2010 ª2010 Elsevier Inc.Vav1 phosphorylation and Granzyme B release (Figure S3).
Thus, inhibitory receptor signaling through CD94-NKG2A over-
rides Vav1-dependent synergy.
c-Cbl Inhibits Vav1-Dependent Activation Signals
To gain further insight into how PLC-g2 activation may be
achieved by NKG2D and 2B4 synergy, we immunoprecipitated
PLC-g2 from lysates of rested NKL cells stimulated by NKG2D
and 2B4 co-crosslinking and immunoblotted it for phosphotyro-
sine. As before (Figure 1), synergistic tyrosine phosphorylation of
PLC-g2 was observed 2 min after stimulation (Figure S4A). After
a longer exposure, tyrosine-phosphorylated bands in the 95 to
120 kDa range were detected. The 95 kDa tyrosine-phos-
phorylated band comigrated with Vav1 and was also detected
by immunoblotting for pY160-Vav1 (Figure S4B). pY160-Vav1
was also associated with PLC-g2 after stimulation with NKG2D
alone. A tyrosine-phosphorylated band at 120 kDa that asso-
ciated with PLC-g2 comigrated with c-Cbl (data not shown).
We therefore tested the possible involvement of Cbl proteins in
regulating signals delivered through PLC-g2 and Vav1.
c-Cbl and Cbl-b are negative regulators of signaling by
lymphocyte receptors (Huang and Gu, 2008). By promoting
ubiquitylation, Cbl proteins control the degradation or the
Figure 3. Coactivation by NKG2D and 2B4 Ligands Is Vav1 Depen-
dent
(A) Rested NKL cells were mixed with S2, S2-ULBP1, S2-CD48, or S2-
ULBP1+CD48 insect cells, as indicated. After incubation for 20 or 40 min,
Vav1 was immunoprecipitated from lysates and immunoblotted for p-Tyr
and pY160-Vav1. Blots were reprobed for Vav1. The normalized intensities
of the phosphorylated Vav1 at tyrosines or at tyrosine 160 relative to total
Vav1 are presented.
(B) Granzyme B release assay with rested NKL cells that were transfected with
control siRNA or Vav1-specific siRNA and incubated with S2 cells or S2 cells
expressing ULBP1 and/or CD48, as indicated. After incubation for 2 hr,
granzyme B in the supernatants was measured by ELISA. The increase of
granzyme B after incubation with target cells relative to granzyme B upon
incubation of NKL cells alone (DGranzyme B) is presented. Values represent
mean ± SD. Data are representative of at least three independent experiments.
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potential role of Cbl in signaling by NKG2D and 2B4, using
siRNA-mediated knockdown of c-Cbl and Cbl-b (Figure S4C).
The Ca2+ mobilization induced by NKG2D and 2B4 synergy in
NKL cells was clearly enhanced by knockdown of c-Cbl (Fig-
ure 4A). Knockdown of Cbl-b caused a reduction in the magni-
tude of Ca2+ mobilization. Furthermore, c-Cbl knockdown
rendered otherwise unresponsive NKL cells responsive to the
engagement of either NKG2D or 2B4 alone (Figure 4A). Although
Ca2+ mobilization induced by NKG2D or by 2B4 after c-Cbl
knockdown was low, robust degranulation, as measured by
Granzyme B release, was detected after mixing NKL cells with
S2 cells expressing either ULBP1 or CD48 (Figure 4B). The Gran-
zyme B release induced by NKG2D and 2B4 synergy was further
enhanced after c-Cbl knockdown (Figure 4B). c-Cbl knockdown
also enhanced IFN-g production in response to NKG2D and 2B4
synergy and promoted IFN-g secretion in response to NKG2Dalone (Figure 4C). The bypass of the requirement for synergy
observed after c-Cbl knockdown shows that c-Cbl serves as a
gatekeeper and imposes a requirement for synergistic activation
signals.
c-Cbl knockdown enhanced the phosphorylation of PLC-g2
and Erk observed during NKG2D and 2B4 synergy (Figure 4D).
Although phosphorylation of PLC-g2 and Erk after stimulation
by NKG2D and by 2B4 alone was augmented by c-Cbl knock-
down, it remained lower than the phosphorylation obtained
during synergistic activation. Similarly, phosphorylation of Vav1
was enhanced by c-Cbl knockdown (Figure 4E). Although Vav1
phosphorylation induced by NKG2D after c-Cbl knockdown
was equivalent to that induced by NKG2D and 2B4 synergy,
the Vav1 phosphorylation induced by 2B4 after c-Cbl knock-
down was not (Figure 4E). Therefore, degranulation by NKL cells
is not controlled simply by a threshold of either Vav1 or PLC-g2
phosphorylation.
Tyrosine phosphorylation of c-Cbl was detected after stimula-
tion of rested NKL cells for 2 min by NKG2D, 2B4, or the syner-
gistic NKG2D and 2B4 combination (Figure 4F). A c-Cbl-associ-
ated tyrosine-phosphorylated protein of 95 kDa was also
observed, as was pY160-Vav1 (Figure 4F). To test whether
c-Cbl promoted ubiquitylation of Vav1, we treated NKL cells
with c-Cbl siRNA and stimulated them through NKG2D, 2B4,
or both, and Vav1 immunoprecipitates were immunoblotted for
ubiquitin. c-Cbl-dependent ubiquitylation was clearly detected,
even after synergistic activation (Figure 4G). Therefore, the over-
riding of c-Cbl-mediated inhibition during synergistic activation
does not occur through protection of Vav1 from ubiquitylation.
To obtain further evidence for Vav1 ubiquitylation, we trans-
fected NKL cells with an HA-tagged ubiquitin, triggered through
NKG2D and 2B4, and anti-HA immunoprecipitates were immu-
noblotted for pY160-Vav1. Several bands in the 105 kDa to
150 kDa range (i.e., larger than nonubiquitylated 95 kDa
Vav1) were detected (Figure S4D). Therefore, phosphorylated
Vav1 is ubiquitylated during activation of NKL cells. The time
course and the intensity of Vav1 ubiquitylation correlated closely
with Vav1 phosphorylation (Figure S4E). Preclearing of c-Cbl
removed a large fraction of both phosphorylated and ubiquity-
lated Vav1 (Figure S4F), suggesting that c-Cbl targets phos-
pho-Vav1 for ubiquitylation. Finally, to test whether Vav1 ubiqui-
tylation leads to its rapid degradation, we monitored the kinetics
of Vav1 phosphorylation and of the Vav1-dependent Erk phos-
phorylation after inhibition of proteasome-mediated degradation
with MG132. The decay of phosphorylated Vav1 and Erk was
delayed only slightly during proteasome inhibition (Figure S4G).
Therefore, Vav1 is dephosphorylated more rapidly than it is
degraded.
The enhanced NK cell responses to receptor signaling after
c-Cbl knockdown could be explained by the release from inhibi-
tion of a bypass activation pathway, independent of Vav1. Such
a scenario occurs in the c-Cbl-mediated regulation of T cell
development (Chiang et al., 2009; Chiang et al., 2004). The block
of thymic positive selection in SLP76-deficient and SLP76 mutant
mice was rescued in mice doubly deficient in SLP76 and c-Cbl.
The role of c-Cbl in that case is to serve as gatekeeper to prevent
signaling by a SLP76-independent pathway. To test whether
a similar regulation by c-Cbl occurs in the case of Vav1-depen-
dent NK cell activation, we performed double-knockdownImmunity 32, 175–186, February 26, 2010 ª2010 Elsevier Inc. 179
Figure 4. c-Cbl Limits NK Cell Activation and Imposes a Requirement for Synergy
(A) Calcium flux in rested NKL cells transfected with either control siRNA or siRNA specific for c-Cbl or Cbl-b and stimulated with NKG2D and 2B4 as in
Figure 2A.
(B) Granzyme B released by rested NKL cells transfected with control siRNA or c-Cbl-specific siRNA and incubated with S2 cells or S2 cells expressing ULBP1,
CD48, or both, as in Figure 3B. Values (DGranzyme B) represent mean ± SD.
(C) IFN-g released by rested NKL cells transfected with control siRNA or c-Cbl-specific siRNA and stimulated with beads coated with isotype control mAb
(cIgG1) or mAbs to NKG2D and 2B4 as in Figure 2C. Values represent mean ± SD.
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Figure 5. Signals Inhibited by c-Cbl Are Vav1 Dependent
(A) Calcium flux in rested NKL cells transfected with either control siRNA or siRNAs specific for Vav1 and for c-Cbl. NKL cells were stimulated with Abs to NKG2D
and 2B4 as in Figure 2A.
(B) Granzyme B released by rested NKL cells transfected with control siRNA or siRNAs specific for Vav1 and for c-Cbl and incubated with S2 cells or S2 cells
expressing ULBP1, CD48, or both, as in Figure 3B. Values (DGranzyme B) represent mean ± SD.
(C) Calcium flux in rested NKL cells transfected with either control siRNA or siRNA specific for c-Cbl and stimulated with Abs to NKG2D and 2B4 combined with or
without a mAb to CD94, as in Figure 2A.
(D) Lysis of 221 cells by rested NKL cells either mock-transfected or transfected with control siRNA or siRNAs specific for Vav1 and for c-Cbl.
(E) Lysis of 221 or 221-AEH cells by rested NKL cells transfected with control siRNA or siRNA specific for c-Cbl. Error bars represent the SD. Data are represen-
tative of at least three independent experiments.
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NK Receptor Synergy Overcomes Inhibition by c-Cblexperiments with siRNA to Vav1 and c-Cbl (Figure S5). The defect
in Ca2+ mobilization and Granzyme release due to Vav1 knock-
down was not rescued by the combined c-Cbl knockdown
(Figures 5A and 5B). Therefore, c-Cbl controls Vav1-dependent
signals.(D) Rested NKL cells transfected with control siRNA or c-Cbl-specific siRNA we
After receptor crosslinking for 2 min, lysates were immunoblotted for pY1217-PL
intensities of the phosphorylated PLC-g2 and Erk1 and 2 relative to actin are pr
(E) Rested NKL cells were treated as in Figure 1A for stimulation of NKG2D and 2
and probed with a mAb to p-Tyr (top) and an Ab to pY160-Vav1 (bottom). The arr
which was visible after a long exposure. The blots were stripped and reprobed
(F and G) Rested NKL cells transfected with control siRNA or c-Cbl-specific siRNA
both. After receptor crosslinking for 2 min, Vav1 was immunoprecipitated from lys
Blots were reprobed for Vav1. The normalized intensities of the phosphorylated V
representative of at least four independent experiments.Inhibition by CD94-NKG2A Is Independent of c-Cbl
Next, we examined whether the inhibition of NKG2D and 2B4
synergy by CD94-NKG2A, an inhibitory receptor specific for
HLA-E, relied on the inhibitory contribution of c-Cbl. Ca2+ mobi-
lization induced by NKG2D and 2B4 synergy was inhibited byre stimulated with isotype control mAb (cIgG1) or mAbs to NKG2D and 2B4.
C-g2, p-Erk1 and 2, and c-Cbl. Blots were reprobed for actin. The normalized
esented.
B4 at 37C for the indicated time. c-Cbl was immunoprecipitated from lysates
ow points to a distinct tyrosine-phosphorylated protein associated with c-Cbl,
for c-Cbl.
were stimulated with isotype control mAb (cIgG1) or mAbs to NKG2D, 2B4, or
ates and probed with Abs to p-Tyr or pY160-Vav1 (F) or an Ab to ubiquitin (G).
av1 at tyrosines or at tyrosine 160 relative to total Vav1 are presented. Data are
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Figure 6. c-Cbl Overexpression Inhibits NKG2D and 2B4 Synergy
NKL cells were transfected with 8 mg of YFP vector control or c-Cbl-YFP
plasmid. After 24 hr, cells were sorted for YFP+ cells.
(A) Rested NKL cells transfected with the indicated plasmid were stimulated
with isotype control mAb (cIgG1) or mAbs to NKG2D and 2B4. After receptor
crosslinking for 2 min, lysates were immunoblotted for pY1217-PLC-g2,
p-Erk1 and 2, and pY160-Vav1. Blots were reprobed for c-Cbl and actin.
The normalized intensities of the phosphorylated PLC-g2, Erk1 and 2, and
Vav1 at tyrosine 160 relative to actin are presented.
(B) Redirected lysis of P815 cells by rested NKL cells transfected with the
indicated plasmid at an effector to target cell ratio of 10. NKL cells were
stimulated with mAbs to NKG2D, 2B4, or both. Error bars represent the SD.
(C) Granzyme B released by rested NKL cells transfected with the indicated
plasmid and incubated with S2 cells or S2 cells expressing ULBP1, CD48, or
both, as in Figure 3B. Values (DGranzyme B) represent mean ± SD. Data are
representative of at least three independent experiments.
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(Figure 5C). To validate these results in the physiological context
of NK–target cell contacts, we tested the cytotoxic activity of res-
ted NKL cells toward the HLA class I-negative human cell line
722.221 (referred to as 221) and 221 cells with cell-surface
expression of HLA-E (221-AEH). Lysis of 221 cells was enhanced
after c-Cbl knockdown and inhibited after knockdown of Vav1
(Figure 5D). As observed after synergistic activation of degranu-
lation (Figure 5B), a very small amount of lysis was recovered
after combined knockdown of c-Cbl and Vav1 (Figure 5D). As
expected, 221-AEH cells were protected from lysis by NKL cells
(Figure 5E). This HLA-E-dependent inhibition was dominant over
the enhancement of activation through c-Cbl knockdown (Fig-
ure 5E). Therefore, inhibitory signaling through CD94-NKG2A
binding to HLA-E is independent of an inhibitory contribution
by c-Cbl.
Increased Vav1 Expression Overcomes Inhibition
by c-Cbl
Despite Vav1 ubiquitylation, c-Cbl exerts only moderate control
over Vav1 phosphorylation. Phosphorylation of Vav1 induced by
crosslinking NKG2D, 2B4, or both was in each case augmented
less than 2-fold after c-Cbl knockdown (Figure 4E). This raises
the question of whether c-Cbl regulates Vav1-dependent signals182 Immunity 32, 175–186, February 26, 2010 ª2010 Elsevier Inc.through inhibition of another signaling component. In that case,
synergistic activation could be due to a signaling pathway that
is independent of the c-Cbl-sensitive component and, hence,
resistant to inhibition by c-Cbl. Such a hypothesis predicts that
c-Cbl overexpression would not inhibit synergistic activation
signals. To test it, we transfected NKL cells with YFP-tagged
c-Cbl and isolated YFP-positive cells by flow cytometry. Expres-
sion of c-Cbl-YFP in those cells was higher than that of endoge-
nous c-Cbl and resulted in a reduction to 1/2 or 1/3 of the
phosphorylation of Vav1, PLC-g2, and Erk after activation by
NKG2D and 2B4 co-crosslinking (Figure 6A). A similar inhibition
was obtained in functional readouts with c-Cbl-YFP expressing
NKL cells, which had reduced cytotoxicity upon NKG2D and
2B4 coengagement (Figure 6B), and reduced Granzyme release
after incubation with S2 cells expressing ULBP1 and CD48
(Figure 6C). Therefore, negative regulation by c-Cbl is, at least
in part, at the level of Vav1-dependent synergistic phosphoryla-
tion of PLC-g2 and is not targeting a protein that is outside of the
Vav1-dependent synergistic activation pathway.
The negative regulation of NK cell responses by c-Cbl at the
level of Vav1 during activation by a single receptor, such as
NKG2D or 2B4, leads to the prediction that Vav1 overexpression
may override c-Cbl-mediated inhibition and bypass the require-
ment for synergy. Conversely, if activation through a single re-
ceptor required complementation by a c-Cbl-sensitive signaling
component outside of the Vav1-PLC-g2 axis, Vav1 overexpres-
sion would not override c-Cbl-mediated inhibition. To test these
hypotheses, we transfected NKL cells with YFP-tagged Vav1
and isolated YFP-positive cells by flow cytometry. A mem-
brane-targeted form of Vav1 carrying a CAAX palmitoylation
motif at the C terminus was also used. As expected, YFP-Vav1
was dispersed throughout the cytosol, whereas YFP-Vav1-
CAAX was distributed at the cell periphery (Figure 7A). Expres-
sion of YFP-tagged forms of Vav1 in those cells was higher
than that of endogenous Vav1 and resulted in a drastic change
of the PLC-g2 and Erk phosphorylation induced by either
NKG2D or 2B4 (Figure 7B). In the presence of YFP-Vav1, phos-
phorylation of PLC-g2 tyrosine 1217 was no longer synergistic;
NKG2D and 2B4 engagement each induced phosphorylation,
and their coengagement resulted in an additive amount of phos-
phorylation (Figure 7B). The impact of membrane-targeted YFP-
Vav1 on PLC-g2 phosphorylation was even greater; NKG2D and
2B4 crosslinking each induced a PLC-g2 phosphorylation similar
to that obtained by NKG2D and 2B4 coengagement (Figure 7B).
Erk phosphorylation was also greatly enhanced by membrane-
targeted YFP-Vav1; NKG2D and 2B4 engagement each induced
Erk phosphorylation, and their coengagement resulted in an
additive amount of phosphorylation (Figure 7B). In functional
readouts for cytotoxicity and Granzyme release, expression of
YFP-Vav1 in NKL cells was sufficient to bypass the requirement
for synergy (Figures 7C and 7D). Because Vav1 overexpression
overcomes c-Cbl-mediated inhibition, we conclude that c-Cbl
imposes a requirement for synergistic activation of NK cells
through downregulation of Vav1-dependent signals.
DISCUSSION
Activation of primary NK cells, freshly isolated from human blood,
is tightly regulated and requires signaling by combinations of
Figure 7. Increased Vav1 Expression Overcomes Inhibition by c-Cbl
NKL cells were transfected with 8 mg of YFP vector control, YFP-Vav1, or
YFP-Vav1 CAAX plasmid. After 24 hr, cells were sorted for YFP+ cells.
(A) Representative confocal images of NKL cells transfected with the indicated
plasmid.
(B) Rested NKL cells transfected with the indicated plasmid were stimulated
with isotype control mAb (cIgG1) or mAbs to NKG2D, 2B4, or both. After
receptor crosslinking for 2 min, lysates were immunoblotted for pY1217-
PLC-g2, p-Erk1 and 2, and pY160-Vav1. Blots were reprobed for Vav1 and
actin. The normalized intensities of the phosphorylated PLC-g2 and Erk1
and 2 relative to actin are presented.
(C) Redirected lysis of P815 cells by rested NKL cells transfected with the
indicated plasmid at an effector to target cell ratio of 10. NKL cells were
stimulated with mAbs to NKG2D, 2B4, or both. Error bars represent the SD.
(D) Granzyme B released by rested NKL cells transfected with the indicated
plasmid and incubated with S2 cells or S2 cells expressing ULBP1, CD48, or
both, as in Figure 3B. Values (DGranzyme B) represent mean ± SD. Data are
representative of at least three independent experiments.
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(Bryceson et al., 2009; Bryceson et al., 2006a). The main question
addressed here was how signals from complementary receptors
synergize. Is the requirement for synergy due to complementa-
tion of distinct and necessary signals or to a convergence of
signals that have to override an activation threshold? Using coac-
tivation by receptors NKG2D and 2B4 as a model, we have found
that they synergize for PLC-g activation by a pathway that is
completely dependent on Vav1 and under negative regulation
by c-Cbl. Synergy is not achieved by signals that complement
Vav1-dependent signals, nor by inhibition of c-Cbl-mediated
ubiquitylation, but is required to overcome c-Cbl-mediated
inhibition of Vav1-dependent signals.
Synergistic signaling by NKG2D and 2B4 induced degranula-
tion but not granule polarization, which is dependent on the b2
integrin LFA-1 (Bryceson et al., 2005). Therefore, our experi-
mental approach avoided potential complications due to the
contribution of Vav1 to ‘‘inside-out’’ signaling for LFA-1 (Ardouin
et al., 2003; Krawczyk et al., 2002). Using Abs to crosslink recep-
tors NKG2D and 2B4, or Drosophila S2 cells expressing receptor
ligands in the absence of LFA-1 ligands, we have shown that
Vav1 has an indispensable role in synergistic signaling by
NKG2D and 2B4 for PLC-g2 activation, cytokine secretion,
degranulation, and cytotoxicity by NK cells. Vav1 was also
required for synergistic signaling by the combination of recep-
tors 2B4 and DNAM-1.
Our results revealed that synergy does not occur by mutual
amplification of NKG2D and 2B4 proximal signaling, but occurs
downstream of 2B4 phosphorylation and recruitment of the
adaptor SAP, which were not enhanced by co-crosslinking
with NKG2D. Conversely, PI3K-dependent phosphorylation of
Akt induced by NKG2D crosslinking was not enhanced by
co-crosslinking with 2B4. NKG2D signaling was sufficient
to induce phosphorylation of Vav1 and its association with
PLC-g2. The C-terminal SH2 domain of PLC-g binds to a phos-
phorylated tyrosine in the regulatory, acidic domain of Vav1
(Miletic et al., 2006). 2B4 signaling was sufficient for inducing
a low amount of PLC-g phosphorylation. Synergistic phosphor-
ylation of PLC-g by the coengagement of NKG2D, which can
recruit Vav1 through the adaptor Grb2 (Graham et al., 2006; Up-
shaw et al., 2006), and 2B4 may be due to a combination of Vav1
recruitment and phosphorylation. In support of this hypothesis,
a membrane-targeted form of Vav1 synergized with 2B4 signals
to overcome the dependence on NKG2D signaling.
c-Cbl and Cbl-b are multifunctional adaptor molecules with
ubiquitin ligase activity, which regulate signaling by diverse
receptors (Huang and Gu, 2008). Cbl-mediated ubiquitylation
of receptors can result in internalization from the cell surface
and delivery to lysosomal compartments. Ubiquitylation of cyto-
solic signaling molecules can lead to degradation by protea-
somes. In our study, c-Cbl-dependent ubiquitylation of Vav1
was detected. However, the total amount of cellular Vav1 did
not change appreciably under the different stimulation condi-
tions, consistent with the fact that only a small fraction of total
Vav1 was phosphorylated and ubiquitylated. Furthermore,
because inhibition of proteasomal degradation had a very small
effect on the half-life of phosphorylated Vav1, ubiquitylation may
inhibit Vav1 signaling independently of degradation, as was
shown for the inhibition of PI3K in primary T cells throughImmunity 32, 175–186, February 26, 2010 ª2010 Elsevier Inc. 183
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tion (Fang and Liu, 2001).
c-Cbl is required for T cell development past the double-nega-
tive stage and inhibits TCR signals through ubiquitylation of the
TCR z chain (Naramura et al., 1998; Wang et al., 2001) and
Vav1 (Miura-Shimura et al., 2003) and by promoting internaliza-
tion of LAT (Balagopalan et al., 2007). Work in mice with single
and double deficiencies in c-Cbl and the adaptor SLP76 showed
that c-Cbl inhibits a bypass signaling pathway that is indepen-
dent of SLP76, given that a double SLP76 and c-Cbl deficiency
restored development (Chiang et al., 2009; Chiang et al., 2004).
In contrast, in our study with NK cells, c-Cbl knockdown did not
rescue the Vav1 defect, implying that c-Cbl regulates a Vav1-
dependent signaling pathway. Overexpression of c-Cbl and
Vav1 led to further mechanistic insights into the synergy-depen-
dent activation of NK cells. If c-Cbl were to regulate a Vav1-inde-
pendent pathway, c-Cbl overexpression would not overcome
Vav1-dependent synergistic activation signals. However, inhibi-
tion of synergistic activation by overexpression of c-Cbl provided
independent evidence that c-Cbl regulates Vav1-dependent
signaling. If c-Cbl were to control an obligate complement
to Vav1 signals, Vav1 overexpression would not overcome inhi-
bition by c-Cbl. However, Vav1 overexpression resulted in
permissive NK cell degranulation after stimulation with S2 cells
expressing either ULBP1 or CD48 and in phosphorylation of
PLC-g2 after stimulation with NKG2D or 2B4 alone. These results
exclude the possibility of an obligate complement to Vav1 signals
that is controlled by c-Cbl. Synergistic signals from NKG2D and
2B4 did not block c-Cbl phosphorylation or Vav1 ubiquitylation,
but were required to overcome inhibition by c-Cbl. Whereas the
mechanism by which c-Cbl regulates activation signals in NK
cells is very different from that by which c-Cbl regulates signaling
for T cell development, it exhibits similarities to inhibition by Cbl-b
in naive T cells, which has to be overcome by CD28 through
activation of Vav1 (Huang and Gu, 2008). The assignment of
specific functions to Cbl isoforms is therefore different in T cells
and NK cells.
Inhibition of NK cell responses by ITIM-containing receptors
occurs at a proximal step, upstream of Ca2+ mobilization and
of actin polymerization-dependent processes (Long, 2008).
The identification of Vav1 as a primary substrate for dephosphor-
ylation by SHP-1 during inhibitory receptor engagement by MHC
class I on target cells (Peterson and Long, 2008; Stebbins et al.,
2003), and as an essential component in the NKG2D and 2B4
synergy, as shown here, provides an explanation for the domi-
nance of inhibitory receptors over synergistic activation signals.
Our results have revealed a hierarchy of inhibitory signals to
control NK cell activation: a Vav1-dependent synergy is required
to overcome inhibition by c-Cbl but is dominantly inhibited by
CD94-NKG2A, even when inhibition by c-Cbl had been lifted.
The expression of ligands for synergistic natural cytotoxicity
receptors correlated with the sensitivity of primary tumor cells
to killing by freshly isolated, primary NK cells (Carlsten et al.,
2007). Given that the coactivation receptor NKG2D provides
innate protection from spontaneous tumor cells (Guerra et al.,
2008; Smyth et al., 2005), and downregulation of Cbl-b in mice
results in spontaneous tumor rejection by CD8 T cells (Chiang
et al., 2007; Loeser et al., 2007), our new understanding of the
regulation of NK cell responses through c-Cbl, and the184 Immunity 32, 175–186, February 26, 2010 ª2010 Elsevier Inc.synergy-independent activation through individual receptors
after c-Cbl downmodulation, may open ways to optimize NK
cell effector functions.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents
Human NK cells were isolated from peripheral blood by negative selection with
the MACS NK isolation kit (Miltenyi) as described (Bryceson et al., 2006b).
Resting NK cells were resuspended in IMDM (Invitrogen) supplemented with
10% human serum (Valley Biomedical) and used within 2 days of isolation.
The human NK cell line NKL (gift of M. Robertson) was cultured in RPMI
supplemented with 10% FBS, 1 mM sodium pyruvate, and 200 U/ml rIL-2.
NKL cells were rested in 5% FBS without rIL-2 for 24 hr. YTS cells, NK92
cells, and NK3.3 cells were obtained from G. Cohen, H.G. Klingemann, and
J. Kornbluth, respectively. P815 cells (American Type Culture Collection)
were maintained in IMDM supplemented with 10% FBS and 2 mM L-gluta-
mine. 721.221 cells (221; gift of J. Gumperz and P. Parham) and 221 cells
transfected with an HLA-E carrying the HLA-A2 signal peptide (gift of D. Ger-
aghty) were cultured as described (Lee et al., 1998). Transfection and mainte-
nance of the Drosophila S2 cell line has been described (Barber et al., 2004).
Expression of human ligands for NK cell receptor in S2 cells is described in
the Supplemental Information. All chemicals were from Calbiochem unless
indicated otherwise.
Abs
Abs for these proteins were obtained from the following sources: NKG2D
(149810; R&D Systems); CD244/2B4 (C1.7; Beckman Coulter); CD226/
DNAM-1 (DX11), CD94 (HP-3D9), and actin (C4) (BD Biosciences); isotype
control mouse IgG1 (MOPC-21; Sigma); phosphotyrosine (4G10), c-Cbl
(7G10), and HA (06-831) (Upstate); Vav1 (H211), PLC-g2 (Q-20), PLC-g2
(B-10), Cbl-b (G-1), Sap (1D12) and Ubiquitin (P4D1) (Santa Cruz); Vav1
(VAV-30), Vav2 (EP1067Y), and pY731-c-Cbl (EP973Y) (Abcam); pY160 Vav1
(Biosource); and Vav1 (2153), Vav3 (2398), pY759 PLC-g2 (3874), pY1217
PLC-g2 (3871), pS473 Akt (9271), Akt (9272), pErk (9101), and Erk (9102)
(Cell Signaling). Goat F(ab0)2 anti-mouse IgG and PE-conjugated anti-mouse
secondary Ab were from Jackson Immunoresearch. Anti-mouse and rabbit
Abs conjugated to horseradish peroxidase (HRP) were from Santa Cruz.
Anti-rat-HRP and streptavidin-HRP were from GE Healthcare.
Cellular Assays
Degranulation of NK cells was determined by cell-surface expression of
CD107a and by Granzyme B release (Cell Sciences) as described (Bryceson
et al., 2005). Intracellular Ca2+ flux was measured by flow cytometry after
labeling with 2 mM Fluo-4 AM (Invitrogen), as described (Bryceson et al.,
2006b). NK cell cytotoxicity against P815 and 221 cells were determined
by a Europium assay (Peterson and Long, 2008). IFN-g (Pierce) and MIP-1a
(R&D Systems) release after stimulation by beads coated with mAbs to NK
receptors were determined by ELISA as described (Bryceson et al., 2006b).
RNA Interference
NKL cells were transfected with 300 pmoles of siRNAs with Amaxa Nucleofec-
tor II system. A total of 23 106 cells were resuspended in 100 ml of Amaxa Kit V,
mixed with siRNA, and immediately transfected wth program O-017. For a total
of 48 hr incubation at 37C, cells were rested for the last 24 hr and then
assayed as indicated. The following siRNA sequences were used: Vav1, 50-CG
UCGAGGUCAAGCACAUU-30; c-Cbl, 50-CCUCUCUUCCAAGCACUGA-30;
Cbl-b, 50-GGACAGACGAAAUCUCACA-30. Prevalidated Vav2 and Vav3-
specific siRNAs were purchased from QIAGEN. The negative siRNA control
was obtained from Dharmacon. Comparable results were obtained with
ON-TARGETplus SMARTpool siRNA specific for Vav1 (Dharmacon).
DNA Constructs and Transfections
A human Vav1 cDNA (a gift of D. Billadeau, Mayo Clinic College of Medicine)
was subcloned into pEYFP-C1 (Clontech) to tag YFP at the N-terminus of
Vav1 (YFP-Vav1).
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an oligonucleotide encoding the 12 C-terminal amino acids of RhoA was
inserted by ‘‘loop-in’’ mutagenesis with QuikChange (Stratagene), such that
this membrane-targeting sequence of RhoA was incorporated at the C
terminus of Vav1. All final constructs were verified by sequencing. The
c-Cbl-YFP and HA-tagged ubiquitin plasmids were provided by L. Samelson
(National Cancer Institute) and D. Bohmann (University of Rochester), respec-
tively. NKL cells (53 106 cells) were transfected with 5–8 mg of plasmid DNA by
Amaxa Nucleofector II, solution V, and program O-017. Transfected cells were
assayed 24 hr posttransfection after a period of rest.
Receptor Crosslinking and Cell Mixing Experiments
For Ab-mediated crosslinking of NK receptors, NK cells were preincubated
with 10 mg/ml isotype control mAb or mAbs specific for NK receptors for
30 min on ice. After washing with medium, NK cells were stimulated by cross-
linking with 30 mg/ml goat anti-mouse F(ab0)2 Ab at 37C for the indicated
times. For cell mixing, NK cells and S2 target cells separately chilled on ice
were mixed at an effector to target ratio of 1. Cells were incubated for
20 min on ice and then transferred to 37C for the indicated times. Cells
were moved to ice and then lysed for further analysis.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/j.
immuni.2010.02.004.
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